2m 2m 2m 2m 2m 2m 2m
Jazz Pharmaceuti (JAZZ)
NASDAQ
$249.10+$0.86 (+0.35%)
Price as of Nov 12, 2026 8:38 AM EST- $15.3BMarket Cap
- 81.58%1-Year Change
- BiotechnologyIndustry
Jazz Pharmaceuti (JAZZ)
$249.10+$0.86 (+0.35%)
JAZZ | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $248.24 | ||
Change | +$2.81 (+1.14%) | ||
Open | $244.24 | ||
High | $248.97 | ||
Low | $243.76 | ||
Previous Close | $245.43 | ||
Volume | 592,854 | ||
30-Day Average Volume | 828,393 | ||
1-Week Change | 5.79% | ||
1-Month Change | 13.65% | ||
1-Year Change | 81.58% | ||
3-Year Change | 106.52% | ||
5-Year Change | 83.22% | ||
Fundamentals | |||
Shares Outstanding | 61.6M | ||
Total Assets | $12.0B | ||
Market Cap | $15.3B | ||
Enterprise Value | $18.8B | ||
Period: QTR TTM FY | |||
Revenue | $1.2B | ||
Net Income | -$483.4M | ||
Free Cash Flow | $489.9M | ||
EBIT | -$413.4M | ||
EBITDA | -$241.6M | ||
Net Working Capital | $2.1B | ||
EPS | -$7.48 | ||
Enterprise Value/EBITDA | -78 | ||
Enterprise Value/Revenue | 16 | ||
P/B | 4 | ||
P/E | -33 | ||
PEG | 0 | ||
Price/Free Cash Flow | 31 | ||
Price/Operating Cash Flow | 30 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue